Dr. Jan Verbakel en Dr. Dominique Schrijvers
0666.446.319 · rovalta.com · 27/09/2026
Dr. Jan Verbakel en Dr. Dominique Schrijvers
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr. Jan Verbakel en Dr. Dominique Schrijvers is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0666.446.319
- Incorporation
- 17/11/2016
- Legal form
- Private limited company
- Registered office
- Ferdinand Verbiestlaan 17
3001 Leuven · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 367,6 k € | +78.3% | 206,2 k € | -31.7% | 301,9 k € | +5.8% | 285,5 k € | +2.8% | 277,8 k € |
| EBITDA | 366,4 k € | +78.5% | 205,2 k € | -31.9% | 301,3 k € | +5.7% | 285 k € | +2.9% | 276,9 k € |
| Operating result | 342,5 k € | +88.4% | 181,8 k € | -34.8% | 279 k € | +4.7% | 266,5 k € | +3.7% | 257,1 k € |
| Net result | 259 k € | +86.0% | 139,2 k € | -34.0% | 210,9 k € | +8.1% | 195 k € | +0.5% | 194 k € |
| Balance sheet | |||||||||
| Equity | 279,5 k € | -60.7% | 711 k € | +14.4% | 621,8 k € | +51.3% | 410,9 k € | +102% | 203,5 k € |
| Total assets | 640,3 k € | -13.2% | 738,1 k € | +16.1% | 635,7 k € | +40.2% | 453,5 k € | -29.2% | 640,4 k € |
| Cash | 583,8 k € | -9.2% | 643 k € | +26.6% | 507,9 k € | +48.8% | 341,3 k € | -37.1% | 542,8 k € |
| Debts | 360,9 k € | +1232% | 27,1 k € | +94.2% | 14 k € | -67.2% | 42,6 k € | -90.3% | 436,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Dominique Schrijvers | Director | since 17/11/2016 |
Jan Verbakel | Director | since 17/11/2016 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Dominique Schrijvers | Manager | since 17/11/2016 |
Jan Verbakel | Manager | since 17/11/2016 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 29/08/2025 | 04/09/2024 | 25/08/2023 | 27/09/2022 | 26/11/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 21/06/2024 | 16/06/2023 | 17/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 19/06/2026 | 31/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 20/06/2025 | 29/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 21/06/2024 | 04/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 16/06/2023 | 25/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 17/06/2022 | 27/09/2022 | Dutch | |
| Micro model | 31/12/2020 | 18/06/2021 | 26/11/2021 | Dutch | |
| Micro model | 31/12/2019 | 19/06/2020 | 26/11/2020 | Dutch | |
| Micro model | 31/12/2018 | 30/06/2019 | 25/03/2020 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 23/11/2018 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Dominique Schrijvers | Director | since 17/11/2016 |
Jan Verbakel | Director | since 17/11/2016 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Dominique Schrijvers | Manager | since 17/11/2016 |
Jan Verbakel | Manager | since 17/11/2016 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025259 k €↑
- 2024Annual accounts 2024139,2 k €↓
- 2023Annual accounts 2023210,9 k €↑
- 2022Annual accounts 2022195 k €↑
- 2021Annual accounts 2021194 k €↑
- 2020Annual accounts 2020138,2 k €↑
- 2019Annual accounts 2019107,8 k €↑
- 2018Annual accounts 201853,7 k €↑
- 2017Annual accounts 201740,1 k €
- 17/11/2016IncorporationPrivate limited company
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Jan Verbakel en Dr. Dominique SchrijversCurrent | CBE, tracked since 27/09/2026 | CBE |
| Dr J. Verbakel en Dr. D Schrijvers | accounts 2021 → 2025 | Accounts 2025 · 2026-00469595 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.